Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sandoz
Pharma
Sandoz, Henlius agree to $322M deal for 3 biosimilars
Sandoz has collaborated with Henlius to gain commercialization rights to three biosimilars for $100.5M up front and $322M if milestones are reached.
Kevin Dunleavy
Aug 17, 2026 10:46am
Sandoz inks dual settlements to resolve most US antitrust claims
Aug 3, 2026 10:18am
How biosimilar developers are embracing next phase of US market
Jul 6, 2026 10:03am
China's BCI nod, AZ, Astellas—Fierce Pharma Asia
Mar 20, 2026 8:00am
Sandoz expands biosimilar collaboration with Samsung Bioepis
Mar 18, 2026 11:05am
Sandoz to break its biosimilars business out from generics
Mar 10, 2026 4:01pm
